Cargando…
Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients
Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effec...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195193/ https://www.ncbi.nlm.nih.gov/pubmed/22022142 http://dx.doi.org/10.4103/0975-3583.85261 |
_version_ | 1782214087806025728 |
---|---|
author | Fares, Auda |
author_facet | Fares, Auda |
author_sort | Fares, Auda |
collection | PubMed |
description | Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis. |
format | Online Article Text |
id | pubmed-3195193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31951932011-10-21 Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients Fares, Auda J Cardiovasc Dis Res Review Article Sleep disorders are the common side effects of beta blockers. Beta blockers have been shown to reduce the production of melatonin via specific inhibition of adrenergic beta1-receptors. Exogenous melatonin, taken in the evening as a supplement, could reduce the central nervous system (CNS) side effects (sleep disorder) associated with beta-adrenergic receptor blockers as well as the potential risk associated with reduction of the melatonin synthesis. Medknow Publications Pvt Ltd 2011 /pmc/articles/PMC3195193/ /pubmed/22022142 http://dx.doi.org/10.4103/0975-3583.85261 Text en Copyright: © Journal of Cardiovascular Disease Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Fares, Auda Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title | Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title_full | Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title_fullStr | Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title_full_unstemmed | Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title_short | Night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
title_sort | night-time exogenous melatonin administration may be a beneficial treatment for sleeping disorders in beta blocker patients |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195193/ https://www.ncbi.nlm.nih.gov/pubmed/22022142 http://dx.doi.org/10.4103/0975-3583.85261 |
work_keys_str_mv | AT faresauda nighttimeexogenousmelatoninadministrationmaybeabeneficialtreatmentforsleepingdisordersinbetablockerpatients |